CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to be Published in the European Journal of Clinical Microbiology and Infectious Diseases - Press Release
Digital Journal,
BERKELEY HEIGHTS, NJ / ACCESSWIRE / December 5, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused…